Sign In
Buy NXGN
$23.94
+0 (+0%)
At Close: Feb 07, 2024
Here's Why You Should Hold on to Glaukos (GKOS) Stock Now
04:27pm, Wednesday, 29'th Dec 2021 Zacks Investment Research
Glaukos Corporation (GKOS) continues to benefit from a robust product portfolio and solid performing iStent technology.
Abbott (ABT) Diagnostic and Nutrition Arms Grow Worldwide
03:11pm, Wednesday, 29'th Dec 2021 Zacks Investment Research
Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
04:02pm, Tuesday, 28'th Dec 2021 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Abbott (ABT) Scales to a 52-Week High: What's Driving It?
12:40pm, Tuesday, 28'th Dec 2021 Zacks Investment Research
Strength in Diabetes Care and Diagnostics businesses is driving Abbott's (ABT) top line.
3 Beaten-Down Medical Product Stocks to Buy on a Turnaround in 2022
09:12am, Tuesday, 21'st Dec 2021
Here are some medical product stocks from the MedTech sector - Quidel (QDEL), Cerus (CERS) and NextGen Healthcare (NXGN) - which might be witnessing a turnaround in 2022 and be solid investment option
NextGen Enterprise Leveraged by El Centro Family Health to Provide Growing Array of Health Services
05:40pm, Monday, 20'th Dec 2021 Kwhen FinanceNextGen's (NXGN) Integrated Platform Gets Adopted by Monmouth
10:45am, Thursday, 09'th Dec 2021
NextGen's (NXGN) comprehensive solution suite was adopted by Monmouth to better cater to patients' medical and dental needs.
Nextgen Healthcare Inc (NXGN) CFO James Robert Jr. Arnold Bought $77,350 of Shares
03:15pm, Wednesday, 01'st Dec 2021 GuruFocus
Related Stocks: NXGN ,
Here's Why You Should Invest in NextGen (NXGN) Stock Now
10:44am, Wednesday, 01'st Dec 2021
NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR.
Wall Street Analysts Predict a 25% Upside in Nextgen Healthcare (NXGN): Here's What You Should Know
11:30am, Thursday, 25'th Nov 2021
The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in Nextgen Healthcare (NXGN). While the effectiveness of this highly sought-after metric is questionable,
NextGen Healthcare Partners with Prominent Psychiatrist Dr. Gail Saltz to Shine Light on Mental Health Support
01:00pm, Thursday, 18'th Nov 2021 Kwhen Finance
Nextgen Healthcare Inc (NXGN): Price Now Near $16.83; Daily Chart Shows An Uptrend on 50 Day Basis
03:18pm, Wednesday, 17'th Nov 2021 ETF Daily News
This move is a reversal from the day prior, which saw price move up. The post Nextgen Healthcare Inc (NXGN): Price Now Near $16.83; Daily Chart Shows An Uptrend on 50 Day Basis appeared first on ETF Daily News .
NextGen Healthcare to Participate in Upcoming Virtual Healthcare Investor Conferences
08:30am, Thursday, 04'th Nov 2021
ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and Chief Executive Officer, David Side
Nextgen Healthcare (NXGN) Upgraded to Buy: Here's What You Should Know
01:46pm, Tuesday, 02'nd Nov 2021
Nextgen Healthcare (NXGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Can Nextgen Healthcare (NXGN) Climb 27% to Reach the Level Wall Street Analysts Expect?
01:00pm, Tuesday, 02'nd Nov 2021
The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Nextgen Healthcare (NXGN). While the effectiveness of this highly sought-after metric is questionable,
